Is there a pediatric formulation of sucrosomial iron?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 17, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Sucrosomial Iron Pediatric Formulation

Yes, sucrosomial iron is available in pediatric formulations, specifically as oral stick packs designed for direct dissolution in the mouth, though it is not specifically FDA-approved for pediatric use and has limited efficacy data in children. 1

Product Availability

Sucrosomial iron exists as an oral dietary supplement formulation that can be used in pediatric populations. The product comes as single-dose stick packs (1 stick per day) that dissolve directly in the mouth without water, making administration easier in children 1. The formulation contains ferric pyrophosphate protected by a phospholipid bilayer plus a sucrester matrix, designed to pass through the gastric environment intact and be absorbed in the intestine 1.

Critical Safety Warning

The FDA drug label carries a black box warning: accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6 years of age. This product must be kept out of reach of children, and any accidental overdose requires immediate contact with a doctor or poison control center 1.

Pediatric Efficacy Concerns

Recent evidence raises significant concerns about sucrosomial iron's effectiveness in pediatric prophylaxis:

  • A 2025 study comparing iron prophylaxis strategies in 248 infants found that sucrosomial iron was significantly inferior to ferric iron (Fe+3) for preventing iron deficiency anemia 2
  • Infants receiving sucrosomial iron had significantly lower hemoglobin, mean corpuscular volume (MCV), ferritin, and transferrin saturation levels compared to those receiving Fe+3 2
  • While adherence and duration of prophylaxis were similar between groups, the clinical outcomes favored traditional ferric iron preparations 2

Alternative Pediatric Iron Options

The evidence strongly supports other iron formulations for pediatric use:

For Oral Iron Therapy:

  • Ferrous sulfate remains the most widely used and cost-effective option, though gastrointestinal side effects can limit tolerance 3
  • Ferric iron complexes with polysaccharides (iron sucrose, iron gluconate) and amino acid complexes (iron protein succinylate, iron acetyl aspartylate) offer better gastrointestinal tolerance 3
  • Carbonyl iron has excellent bioavailability with a critical safety advantage: high safety margin in accidental overdose, an important consideration given iron's toxicity potential in children 3

For Parenteral Iron:

Iron sucrose is the most studied and recommended intravenous iron preparation in children, with FDA approval from 2 years of age in the USA for iron deficiency anemia in chronic kidney disease 4. The ESPGHAN/ESPEN/ESPR/CSPEN 2018 guidelines provide strong recommendations for iron sucrose use in pediatric populations requiring parenteral iron 4.

Clinical Bottom Line

While sucrosomial iron formulations exist and can be administered to children, the most recent comparative evidence demonstrates inferior efficacy compared to standard ferric iron preparations for pediatric iron deficiency prevention 2. Given this finding, combined with limited pediatric safety and efficacy data, sucrosomial iron should not be considered a first-line option in pediatric populations. Traditional ferrous sulfate, ferric iron preparations, or carbonyl iron (with its superior overdose safety profile) represent better-evidenced choices for pediatric iron supplementation 3.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.